Position in PGEN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$715,923
-$63,227 QoQ
Shares Held
184,994
-0.8% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. PGEN ranks #146 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in PGEN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $715,923 | 184,994 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $779,150 | 186,400 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $350,254 | 106,461 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $167,084 | 117,666 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $94,135 | 63,179 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $22,325 | 19,934 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $15,096 | 15,893 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $79,003 | 50,002 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $46,262 | 31,905 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $122,991 | 86,614 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $164,261 | 142,836 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $376,792 | 355,465 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $831,281 | 546,896 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,313,098 | 619,386 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $654,993 | 488,801 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $568,016 | 269,202 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $805,715 | 217,174 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $365,178 | 73,182 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $333,569 | 51,161 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $595,116 | 86,374 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||